| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ebb6a553affdc364c91cffe3baf12564 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
| filingDate |
1992-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ca36d47a11e747fc370dd1e4126f914 |
| publicationDate |
1993-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9310786-A1 |
| titleOfInvention |
Methods and compositions for treating infection using optically pure (r)-lomefloxacin |
| abstract |
Methods and compositions are disclosed utilizing the optically pure (R)-isomer of lomefloxacin. This compound is a potent drug for the treatment of infection or other diseases requiring antibiotics while avoiding the concomitant liability of adverse effects that are associated with the racemic mixture of lomefloxacin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6534508-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9638147-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6337339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6075024-A |
| priorityDate |
1991-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |